BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cheah E, Huang JG. Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies. World J Gastroenterol 2023; 29(10): 1539-1550 [PMID: 36970587 DOI: 10.3748/wjg.v29.i10.1539]
URL: https://www.wjgnet.com/1007-9327/full/v29/i10/1539.htm
Number Citing Articles
1
Bernardo de Faria Moraes, Gustavo André Pedral Diniz Leite, Luisa Medeiros Visentini, Gabriel André Pedral Diniz Leite, Igor Boechat Silveira, Valbert Oliveira Costa Filho, Luis Pedro Possapp Beis, Leonardo Corrêa Süffert, Pedro Robson Costa Passos, Guilherme Grossi Lopes Cançado. Safety of advanced therapies in pregnant women with inflammatory bowel disease: a systematic review and Meta-AnalysisJournal of Crohn's and Colitis 2026; 20(3) doi: 10.1093/ecco-jcc/jjag035
2
Pooja Kushwaha, Rahila Qureshi, Nooruddin Khan, Sangita Mukhopadhyay. Revolutionizing IBD therapy: Insights into contemporary treatment strategiesInternational Reviews of Immunology 2026; 45(1) doi: 10.1080/08830185.2025.2563522
3
Sidsel Støy, Silvia D’Alessio, Thomas Damgaard Sandahl, Anders Dige, Anne Louise Kjølbye, Rasmus Jorgensen, Silvio Danese, Martijn van de Bunt. Lipidated IL-22 Alone or Combined with Immunomodulatory Agents Improves Disease Endpoints and Promotes Mucosal Healing in a Mouse Model of Chronic Dextran Sodium Sulfate-Induced ColitisDigestive Diseases and Sciences 2025; 70(6) doi: 10.1007/s10620-025-09007-w
4
Xiaona Yang, Hong Guo, Min Zou. Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectivesMolecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-025-00395-z
5
Iyad Issa, Taly Issa. Ethnic divergence in human leukocyte antigen-linked immunogenicity in inflammatory bowel diseaseWorld Journal of Gastroenterology 2026; 32(25): 115526 doi: 10.3748/wjg.115526
6
Hua Huang, Jiaze Ma, An Kang, Tianwei Guo, Wei Sun, Yan Xu, Lijiang Ji. Investigating the molecular mechanisms associated with ulcerative colitis through the application of single-cell combined spatial transcriptome sequencingFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1534768
7
Qing-Chun Zhao, Ying-Shi Zhang, Shuai Wang, Yu Xing, Xin-Zhu Li, Wen-Cheng Min, Kai-Si Yang, Fang-Yuan Zheng. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysisWorld Journal of Gastrointestinal Surgery 2024; 16(2): 571-584 doi: 10.4240/wjgs.v16.i2.571
8
Daniel Schweckendiek, Gerhard Rogler. Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?Digestion 2024; 105(6) doi: 10.1159/000540421
9
Carmen Yagüe Caballero, Santiago García López, Ana Royo Esteban, Laura Figueras Panillo, Pilar Nos, Luisa de Castro, M. Dolores Martín‐Arranz, Manuel Barreiro‐de Acosta, Elena Ricart, Ruth de Francisco, Eva Iglesias, Antonio Giordano, Pilar Varela, Iago Rodríguez‐Lago, Montserrat Rivero, Beatriz Sicilia, Merce Navarro‐Llavat, Isabel Vera, Carles Suria, Jordi Guardiola, Jesús Barrio, Margalida Calafat, Ana Gutiérrez, Xavier Calvet, David Rafael de la Cruz, Francisco Mesonero, Cristina Martínez Pascual, Javier P. Gisbert, Carla J. Gargallo‐Puyuelo, David Monfort i Miquel, Mónica Sierra, Laura Arranz, Cristina Rodríguez‐Gutiérrez, Rufo Lorente, Fernando Bermejo, Lucía Márquez‐Mosquera, Gisela Torres Vicente, José Lázaro Pérez‐Calle, José M. Huguet, Laura Ramos, Ángel Ponferrada‐Díaz, Daniel Ceballos, Mª. Teresa Diz‐Lois Palomares, Eva Sesé Abizanda, Pablo Vega, Ramón Pajares, Javier Santos Fernández, Elena Betoré, David Busquets, Olga Merino, Carlos Martínez‐Flores, Yamile Zabana, Manuela Josefa Sampedro González, Jone Ortiz de Zarate, Ana Fuentes Coronel, Empar Sainz Arnau, Daniel Carpio, Nuria Jiménez, Ignacio Marín‐Jiménez, Luis Bujanda, Raquel Camargo Camero, Martín Irabien, María Abanades Tercero, Benito Velayos Jiménez, Pilar Robledo Andres, Ana María Trapero, Pedro G. Delgado‐Guillena, Luís Hernández Villalba, Margarita Menacho, Nuria Rull Murillo, Carles Leal, Cristina Alba, Rosa Gómez Espín, Alfredo J. Lucendo, Manuel Van Domselaar, Laura García Alles, Eduardo Iyo Miyashiro, Ana Crespo Catalá, Pau Gilabert, Daniel Martín Rodríguez, Víctor Manuel Navas‐López, María Calvo Iñiguez, Daniel Ginard, Teresa Martínez Pérez, Eugeni Domènech, Diego Casas Deza. Impact of Prior Biologic Mechanism of Action on Anti‐TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry StudyAlimentary Pharmacology & Therapeutics 2026;  doi: 10.1111/apt.70904
10
Luyao Liu, Fan Zhao, Dandan Han, Xin Lü, Gang Wu, Yanglei Yi. Liquiritigenin ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function, reducing endoplasmic reticulum stress and modulating gut microbiotaJournal of Functional Foods 2024; 122 doi: 10.1016/j.jff.2024.106541
11
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovationsWorld Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
12
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
13
Xiaoyu Cai, Yao Yao, Yongquan Zheng, Xuezhi Zhao. Multi-omics gut microbiome signatures for treat-to-target management in inflammatory bowel diseaseMicrobiological Research 2026; 309 doi: 10.1016/j.micres.2026.128511
14
Danny Con, Peter De Cruz. Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling studyIntestinal Research 2024; 22(4) doi: 10.5217/ir.2023.00175